They argue that the fatality rate is much higher, probably 140,000 deaths annually.
The public is surprisingly unsophisticated concerning the proper use of prescribed and non-prescribed drugs. In general, they believe that O.T.C. drugs are safe or they wouldn't be available on the market. They feel that drugs prescribed by physicians are safe because their doctor wouldn't give them anything that would hurt them.
Physicians are confronted by a vast array of drugs, many of which have been introduced since they completed their formal medical training. They frequently have insufficient familiarity with many new drugs to use them well and often the side effects are not emphasized by promotional literature.
The drug industry in this country is a multi-billion dollar operation and over one billion dollars are spent annually to promote products to practicing physicians. In comparison, little is expended by government and industry to evaluate the hazards of drugs after marketing or to promote the safe and effective use of products by physicians and patients.
Knowledge that is presently available concerning factors predisposing to adverse drug reactions is not effectively utilized. It is known that increasing the number of drugs given to patients will result in significant increases in the incidence of adverse drug reactions, yet patients continue to receive far more drugs than are necessary (i.e. antibiotic prophylaxis). Knowledge is presently available which will allow physicians to more accurately calculate dosages in patients with renal disease yet this information is not used by the majority of physicians. There is a pressing need to provide physicians and patients direct access to a drug expert in each and every community but the pharmacist, a person best suited for this role is not being effectively prepared or utilized for this role. Knowledge is now available which could be used to monitor drug therapy of patients but again this function is not adequately performed by most pharmacists. Patient monitoring systems, such as patient medication profiles, have been developed but these have not been implemented by the majority of pharmacists.
Attention should be directed to developing research programs which will identify predisposing factors of adverse drug reactions and implementing programs to prevent their occurrence. Our concern should not be exactly how many deaths occur but rather how can we Drug Intelligence and Clinical Pharmacy VOL 9 implement systems to detect adverse effects of drugs and educate the public and health professionals to decrease the risk of drug therapy.
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Responsibility of Practice THE STUDENT PHARMACIST TODAY is now more than ever facing changes at every turn. Not only is change manifest in the way he is trained, but he is expected to practice in a manner of which even his most recent predecessors are not fully aware. This different training is not new, except to pharmacy education, and hopefully it will instill in our students a more clinically oriented attitude and a sense of patient responsibility. More importantly, this training will strengthen the student's determination to practice as a professional person whether he is employed by another or owns his own practice. All too often, young pharmacists exit their professional education feeling that they are funneled into a type of practice that is personally and professionally unfulfilling. There is no doubt that this occurs, and it provides for dangerously high levels of frustration. One may attempt to assign reasons for this, and they are numerous. However, there are two factors of paramount importance. First is the educational system itself; secondly, the practitioner. Both are indictable. The educational system may be indicted for not assuming the responsibility of providing a relevant information base and a professional attitude adjustment; the practitioner may be indicted for not providing proper direction for pharmacy practice.
Assuming that the educational system is changing for the better, that leaves the practitioner to do his part. What is his part? It consists of numerous responsibilities. Of these, there can be no doubt that his obligations to the patient should be the foundation of his practice. Webster 1 defines responsible as, "involving accountability, obligation, or duties; and hence responsibility as a condition, quality, fact, or instance of being responsibile." Therefore, pharmacists have as members of the health care team a bona fide professional responsibility (accountability, obligation, duty) to provide their patients with the best comprehensive pharmaceutical services. Pharmacy has not lived up to its responsibilities in patient care and concern, and it must.
Pharmacy practice and education have begun to do many positive things; however, they still have far to travel as a profession. The educational system must strive to provide quality in an appropriate and updated sequence of learning experiences. The individual pharmacist must then be the one to accept the commitment of patient responsibility as the base of his clinical practice. Hopefully, the road may become shorter and the direction will be set properly. J. CHRIS BRADBERHY, Pharm.D. World Dictionary, I960, p. 1240 .
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Webster's New
The Five-Year Pharm.D.
IT HAS BEEN SEVERAL YEARS now since some educators first suggested that a Pharm.D. degree be awarded for five years of undergraduate course work. During the summer of 1974, we conducted a survey of residency programs in the United States, and one of the questions dealt with pharmacists" reaction to this proposal. We would like to share some of the replies with you and later comment on this proposal.
As shown in Table 1 , only about one out of five respondents believes that every student should be given a Pharm.D. degree for five years of undergraduate work. 9. Would be meaningless unless the educational system were completely revamped.
Present arguments of those who advocate the fiveyear Pharm.D. go somewhat as follows: 1 Today, Pharm. D. graduates are offered the more attractive clinical and policymaking positions while those with the B.Sc. are assigned the technical and" manipulative tasks. As this process continues, pharmacy will soon be in a position of licensing its technical but not its clinical personnel.
We believe die proponents are confused. They fail to recognize that in all professions it is the holder of the basic degree who is licensed by the state to practice. In law, he who is licensed to practice may obtain his license either by attending Harvard Law School or by taking night classes at a local law school and passing the state bar examinations. A medical student becomes a physician by completing an academic program and passing a state medical examination for licensure. He may become a specialist either by proclaming himself one, or by being certified by a specialty board. There is no separate license for either the corporation lawyer or for the cardiologist. And to imply that a separate license will be required of holders of the Pharm.D. degree is completely erroneous.
In the same way, both the B.Sc. pharmacist and the Pharm.D. pharmacist are licensed to practice pharmacy. The Pharm.D. does not need a separate license to practice, although he may develop a program of board certification which will certify to his qualification to undertake additional professional responsibility. The American Pharmaceutical Association is, in fact, already well on the way toward the establishment of specialty certification. There is no danger nor any need for multiple licensing in pharmacy as there is none in medicine or law.
The proponents claim that the Pharm.D. has not been standardized and that there are at least three levels of preparation. Here they combine programs that permit the student to serve a residency with the six years of required academic work, and thus distort the picture. In essentially all schools offering the Pharm.D., the student can obtain it in six years of academic work. In the one or two cases where a Pharm.D. is not given without a residency, the student can easily find a school which does not require one. If the student chooses to obtain additional training through a residency, that is his option. We believe that Pharm.D. programs are about as well standardized as B.Sc. programs with some strong and others not so strong.
As far as standardization in general is concerned, it
